SMS Lifesciences India Limited has informed the Exchange regarding reappointment of Mr. TV Praveen as Managing Director in the material subsidiary.
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Haleos Labs Limited announced that Mr. Venkata Praveen Talluri has been reappointed as Managing Director of its material subsidiary, Mahi Drugs Private Limited, for a further period of 3 years with effect from June 1, 2025. The reappointment was approved at the 13th Annual General Meeting of the subsidiary held on September 29, 2025. Mr. TV Praveen has over 17 years of experience in the pharmaceutical industry, particularly in APIs and intermediates. The filing also notes that the company's name change from SMS Lifesciences India Limited to Haleos Labs Limited is currently in process. The disclosure is being made under Regulation 30(9) of SEBI LODR, 2015.
This is a routine leadership continuity announcement at a subsidiary level and is unlikely to have a material impact on the stock price. It signals stability in the management of the company's key subsidiary.